Early Life
Alberto Siccardi was born on May 1, 1944. Before his success in the medical device industry, Siccardi's father, Francesco, founded Bieffe Biochimici, a company whose globally offered specialties included dialysis, urology and IV perfusion. In 1997 Baxter International acquired the medical fluids products unit of the company.
Rise to Success
Siccardi's journey to becoming a billionaire began with his own experience: he underwent hip replacement surgery in the early 1990s. Dissatisfied with the process, he was inspired to create better orthopedic solutions. In 1999, Siccardi founded Medacta International, a medical device company specializing in joint replacement and spinal surgery products. Medacta's sales in 2018 were 273 million euros ($307 million). The company's IPO on the Swiss Exchange in April 2019 was a pivotal moment, and valued the family-owned firm at about $2 billion. In 2018, Alberto Siccardi passed the CEO role to his son, Francesco, and took the role of Chairman of the Board.
Key Business Strategies
A key strategy has been Medacta's focus on medical education and sustainability, which resonates with surgeons and healthcare organizations. The company's success is also attributed to its commitment to innovation, with the introduction of products like the AMIS® (Anterior Minimally Invasive Surgery) product line. Medacta has also expanded into new surgical disciplines. Siccardi and his family sold about 6.1 million of their shares (about one third of the total stock) but will still keep effective ownership control of the company they founded. With Francesco Siccardi, the next generation of the Siccardi family will take over the operational responsibility of Medacta International.
Philanthropy
Information regarding specific philanthropy amounts is not readily available through the search results.
